Related Experiment Video

Updated: Mar 18, 2026

Monitoring Protein-Ligand Interactions in Human Cells by Real-Time Quantitative In-Cell NMR using a High Cell Density Bioreactor
10:25

Monitoring Protein-Ligand Interactions in Human Cells by Real-Time Quantitative In-Cell NMR using a High Cell Density Bioreactor

Published on: March 9, 2021

3.9K

CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine

Irving L Weissman1, Fiona M Watt2

  • 1Institute for Stem Cell Biology and Regenerative Medicine and Stanford Ludwig Center for Cancer Stem Cell Research and Medicine, 265 Campus Drive West, Room G3167, Stanford, CA 94305-5461, USA.

Cell Stem Cell
|July 9, 2016
PubMed

Insights

The California Institute for Regenerative Medicine (CIRM) and the UK Regenerative Medicine Platform (UKRMP) share goals for stem cell research translation. Despite differing structures, both aim to advance regenerative medicine from lab to clinic.

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Translational Research

Background:

  • The California Institute for Regenerative Medicine (CIRM) and the UK Regenerative Medicine Platform (UKRMP) are key organizations in advancing stem cell therapies.
  • Both initiatives aim to bridge the gap between basic stem cell research and clinical applications.
  • Despite shared objectives, their operational frameworks exhibit significant divergence.

Purpose of the Study:

  • To compare the organizational structures, funding, and governance of CIRM and UKRMP.
  • To analyze the distinct approaches of CIRM and UKRMP in translating stem cell research.
  • To evaluate the impact of these differing models on the progress of regenerative medicine.

Main Methods:

  • Comparative analysis of institutional frameworks.
  • Review of funding mechanisms and governance models.
  • Assessment of translational outcomes in stem cell research.

Main Results:

  • CIRM and UKRMP possess fundamentally different histories, funding streams, and governance structures.
  • These divergent models influence the pace and direction of stem cell research translation.
  • Key differences impact the efficiency and effectiveness of translating discoveries into clinical practice.

Conclusions:

  • Understanding the contrasting models of CIRM and UKRMP provides insights into optimizing regenerative medicine translation.
  • The study highlights how diverse organizational strategies can impact the development of stem cell therapies.
  • Comparative analysis offers valuable lessons for future regenerative medicine initiatives worldwide.

Related Concept Videos